These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11456622)

  • 1. Polyoxometalate HIV-1 protease inhibitors. A new mode of protease inhibition.
    Judd DA; Nettles JH; Nevins N; Snyder JP; Liotta DC; Tang J; Ermolieff J; Schinazi RF; Hill CL
    J Am Chem Soc; 2001 Feb; 123(5):886-97. PubMed ID: 11456622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 protease inhibition potential of functionalized polyoxometalates.
    Flütsch A; Schroeder T; Grütter MG; Patzke GR
    Bioorg Med Chem Lett; 2011 Feb; 21(4):1162-6. PubMed ID: 21256010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure of dawson polyoxometalate-based, multifunctional, inorganic-organic hybrid compounds: organogermyl complexes with one terminal functional group and organosilyl analogues with two terminal functional groups.
    Nomiya K; Togashi Y; Kasahara Y; Aoki S; Seki H; Noguchi M; Yoshida S
    Inorg Chem; 2011 Oct; 50(19):9606-19. PubMed ID: 21902232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sandwich-type Hf(IV) and Zr(IV)complexes composed of tri-lacunary Keggin polyoxometalates: structure of [M(3)(mu-OH)(3)(A-alpha-PW(9)O(34))(2)](9-) (M = Hf and Zr).
    Saku Y; Sakai Y; Shinohara A; Hayashi K; Yoshida S; Kato CN; Yoza K; Nomiya K
    Dalton Trans; 2009 Feb; (5):805-13. PubMed ID: 19156274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad spectrum anti-RNA virus activities of titanium and vanadium substituted polyoxotungstates.
    Shigeta S; Mori S; Kodama E; Kodama J; Takahashi K; Yamase T
    Antiviral Res; 2003 May; 58(3):265-71. PubMed ID: 12767474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Europium(III) reduction and speciation within a Wells-Dawson heteropolytungstate.
    Jing J; Burton-Pye BP; Francesconi LC; Antonio MR
    Inorg Chem; 2008 Aug; 47(15):6889-99. PubMed ID: 18616240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of triterpenes from Crataegus pinatifida on HIV-I protease.
    Min BS; Jung HJ; Lee JS; Kim YH; Bok SH; Ma CM; Nakamura N; Hattori M; Bae K
    Planta Med; 1999 May; 65(4):374-5. PubMed ID: 10364847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide bond hydrolysis catalyzed by the Wells-Dawson Zr(α2-P2W17O61)2 polyoxometalate.
    Absillis G; Parac-Vogt TN
    Inorg Chem; 2012 Sep; 51(18):9902-10. PubMed ID: 22928475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of A-seco type triterpenoids for anti-HIV-1protease activity.
    Wei Y; Ma CM; Hattori M
    Eur J Med Chem; 2009 Oct; 44(10):4112-20. PubMed ID: 19493591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin mimetic effect of a tungstate cluster. Effect of oral administration of homo-polyoxotungstates and vanadium-substituted polyoxotungstates on blood glucose level of STZ mice.
    Nomiya K; Torii H; Hasegawa T; Nemoto Y; Nomura K; Hashino K; Uchida M; Kato Y; Shimizu K; Oda M
    J Inorg Biochem; 2001 Oct; 86(4):657-67. PubMed ID: 11583783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intercluster compound between a tetrakis{triphenylphosphinegold(I)}oxonium cation and a keggin polyoxometalate (POM): formation during the course of carboxylate elimination of a monomeric triphenylphosphinegold(I) carboxylate in the presence of POMs.
    Nomiya K; Yoshida T; Sakai Y; Nanba A; Tsuruta S
    Inorg Chem; 2010 Sep; 49(18):8247-54. PubMed ID: 20735028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrolysis of DNA model substrates catalyzed by metal-substituted Wells-Dawson polyoxometalates.
    Vanhaecht S; Absillis G; Parac-Vogt TN
    Dalton Trans; 2012 Sep; 41(33):10028-34. PubMed ID: 22595967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tricyclic ureas: a new class of HIV-1 protease inhibitors.
    Han W; Pelletier JC; Hodge CN
    Bioorg Med Chem Lett; 1998 Dec; 8(24):3615-20. PubMed ID: 9934481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99Tc and Re incorporated into metal oxide polyoxometalates: oxidation state stability elucidated by electrochemistry and theory.
    McGregor D; Burton-Pye BP; Mbomekalle IM; Aparicio PA; Romo S; López X; Poblet JM; Francesconi LC
    Inorg Chem; 2012 Aug; 51(16):9017-28. PubMed ID: 22839965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based phenotyping predicts HIV-1 protease inhibitor resistance.
    Shenderovich MD; Kagan RM; Heseltine PN; Ramnarayan K
    Protein Sci; 2003 Aug; 12(8):1706-18. PubMed ID: 12876320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of di- and tripeptide analogues containing alpha-ketoamide as a new core structure for inhibition of HIV-1 protease.
    Sheha MM; Mahfouz NM; Hassan HY; Youssef AF; Mimoto T; Kiso Y
    Eur J Med Chem; 2000 Oct; 35(10):887-94. PubMed ID: 11121614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the interactions of Ti-containing polyoxometalates (POMs) with SARS-CoV 3CLpro by molecular modeling.
    Hu D; Shao C; Guan W; Su Z; Sun J
    J Inorg Biochem; 2007 Jan; 101(1):89-94. PubMed ID: 17049610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulation of anion/cation in the central cavity of tetrameric polyoxometalate, composed of four trititanium(IV)-substituted α-Dawson subunits, initiated by protonation/deprotonation of the bridging oxygen atoms on the intramolecular surface.
    Sakai Y; Ohta S; Shintoyo Y; Yoshida S; Taguchi Y; Matsuki Y; Matsunaga S; Nomiya K
    Inorg Chem; 2011 Jul; 50(14):6575-83. PubMed ID: 21675740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of wild-type and mutant human immunodeficiency virus type 1 proteases by GW0385 and other arylsulfonamides.
    Hanlon MH; Porter DJ; Furfine ES; Spaltenstein A; Carter HL; Danger D; Shu AY; Kaldor IW; Miller JF; Samano VA
    Biochemistry; 2004 Nov; 43(45):14500-7. PubMed ID: 15533054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anti-HIV activity of new C2 symmetric derivatives designed as HIV-1 protease inhibitors.
    Peçanha EP; Figueiredo LJ; Brindeiro RM; Tanuri A; Calazans AR; Antunes OA
    Farmaco; 2003 Feb; 58(2):149-57. PubMed ID: 12581781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.